Journal article · 2025 · Open access
Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity
Immunity, 59(1), 161–176.e12 · Published 19 December 2025 · DOI 10.1016/j.immuni.2025.11.020
In brief
“Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity” is a 2025 journal article by Béatrice Zitti and 44 co-authors, published in Immunity. OpenAlex counts 27 citations as of 16 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Immunity.
- Citations
- 27
- Most cited in
- 2026 (27)
- Field-weighted impact
- 8.05
- References
- 114
- Authors
- 45
Abstract
Tumor-resident CCR7 + dendritic cells (DCs) are key determinants of antitumor T cell responses. Here, we examined the localization of CCR7 + DCs within tumors and the impact of this positioning on antitumor immunity. Spatial, single-cell, and intravital analyses of human cancers and mouse models reveal that CCR7 + DCs form perivascular clusters. Fibroblasts surrounding venous blood vessels produced CCL19, guiding CCR7 + DCs into perivascular niches. Regulatory T (Treg) cells frequently contact perivascular CCR7 + DCs, suppressing CD40 expression and CD4 + and CD8 + T cell activation. Treg cell depletion restored CD40 expression by CCR7 + DCs, enhanced immunostimulatory programs, and improved T cell-dependent tumor control. Anti-PD-1 not only increased perivascular CCR7 + DC clustering and IL-12 production but also strengthened Treg-DC interactions through a CCL22-dependent mechanism, limiting therapeutic efficacy. CCR7 + DCs expressed both co-stimulatory and co-inhibitory molecules, which may underlie their capacity for antitumor activation and concurrent vulnerability to suppression. Modulating the mechanisms that form and restrain CCR7 + DC perivascular immune hubs may improve cancer immunotherapy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zitti, B., Duval, F., Wirapati, P., Hicham, M., Xie, Y., Oh, J., Hoelzl, J., Meiser, P., Varrone, M., Peterson, H. M., Cianciaruso, C., Bill, R., Bayerl, F., Bolli, E., Goubet, A.-G., Kiss, M., McDowell, S. A. C., Cheng, P. F., Celestini, D., . . . Pittet, M. J. (2025). Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity. Immunity, 59(1), 161–176.e12. https://doi.org/10.1016/j.immuni.2025.11.020
MLA 9
Zitti, Béatrice, et al. “Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity.” Immunity, vol. 59, no. 1, 2025, pp. 161–176.e12. https://doi.org/10.1016/j.immuni.2025.11.020.
Chicago
Zitti, Béatrice, Florent Duval, Pratyaksha Wirapati, Mehdi Hicham, Yuxuan Xie, Juhyun Oh, Jan Hoelzl, et al. 2025. “Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity.” Immunity 59 (1): 161–176.e12. https://doi.org/10.1016/j.immuni.2025.11.020.
Harvard
Zitti, B. et al. (2025) ‘Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity’, Immunity, 59(1), pp. 161–176.e12. doi:10.1016/j.immuni.2025.11.020.
IEEE
B. Zitti et al., “Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity,” Immunity, vol. 59, no. 1, pp. 161–176.e12, 2025, doi: 10.1016/j.immuni.2025.11.020.
BibTeX
@article{zitti2025positioning,
title = {{Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity}},
author = {Zitti, Béatrice and Duval, Florent and Wirapati, Pratyaksha and Hicham, Mehdi and Xie, Yuxuan and Oh, Juhyun and Hoelzl, Jan and Meiser, Philippa and Varrone, Marco and Peterson, Hannah M. and Cianciaruso, Chiara and Bill, Ruben and Bayerl, Felix and Bolli, Evangelia and Goubet, Anne-Gaëlle and Kiss, Máté and McDowell, Sheri A. C. and Cheng, Phil Fang and Celestini, Dan and Terzic, Julie and Zwahlen, Thomas and Alouche, Nagham and Zouggari, Nawel and Tarussio, David and Tissot, Stephanie and Nunes-Hasler, Paula and Mino-Kenudson, Mari A. and Lanuti, Michael and Faquin, William C. and Sadow, Peter M. and others},
journal = {Immunity},
year = {2025},
volume = {59},
number = {1},
pages = {161--176.e12},
doi = {10.1016/j.immuni.2025.11.020},
url = {https://doi.org/10.1016/j.immuni.2025.11.020}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- regulatory T cells
- CCL19
- CCL22
- CD40
- T cell suppression
- antitumor immunity
- anti-PD-1 therapy
- IL-12
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Zitti, B., Duval, F., Wirapati, P., Hicham, M., Xie, Y., Oh, J., Hoelzl, J., Meiser, P., Varrone, M., Peterson, H. M., Cianciaruso, C., Bill, R., Bayerl, F., Bolli, E., Goubet, A.-G., Kiss, M., McDowell, S. A. C., Cheng, P. F., Celestini, D., . . . Pittet, M. J. (2025). Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity. Immunity, 59(1), 161–176.e12. https://doi.org/10.1016/j.immuni.2025.11.020
How many times has this paper been cited?
27 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Immunity: sign in and open the full text from this page.
Who wrote this paper?
Béatrice Zitti, Florent Duval, Pratyaksha Wirapati, Mehdi Hicham, Yuxuan Xie, Juhyun Oh, Jan Hoelzl, Philippa Meiser, Marco Varrone, Hannah M. Peterson, Chiara Cianciaruso, Ruben Bill and 33 more.
What is the DOI of this paper?
10.1016/j.immuni.2025.11.020, permanently at https://doi.org/10.1016/j.immuni.2025.11.020. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.